Coronavirus channel feed

Covid-19 roundup: In­dia halts As­traZeneca vac­cine ex­ports as in-coun­try cas­es rise — re­port

5 years ago

Un­der fire, As­traZeneca hus­tles out a pri­ma­ry cut of the num­bers for its Covid-19 vac­cine sup­port­ing pos­i­tive ef­fi­ca­cy

5 years ago
R&D

Covid-19 roundup: EU cracks down fur­ther on vac­cine ex­ports; Pfiz­er en­ters race for Covid-19 pill

5 years ago

Pfiz­er emerges from pan­dem­ic cru­cible with con­fi­dence to go so­lo in tak­ing mR­NA vac­cines be­yond Covid-19

5 years ago
Pharma

Covid-19 roundup: US ex­pects 'nice in­crease' in J&J vac­cine sup­ply — re­port; Cure­Vac amends tri­al pro­to­cols for vari­ant ef­fi­ca­cy

5 years ago

Mid­dle-of-the-night NIH state­ment rais­es con­cerns on As­traZeneca's US vac­cine tri­al read­out

5 years ago
Pharma

Re­gen­eron to seek EUA for low­er dose of Covid-19 mAb cock­tail as new tri­al shows ma­jor drop in risk of hos­pi­tal­iza­tion or death

5 years ago
Pharma

Covid-19 roundup: Dai­ichi's mR­NA shot en­ters the clin­ic; South Africa sells its As­traZeneca sup­ply to neigh­bors

5 years ago

As­traZeneca read­ies April EUA fil­ing with 79% vac­cine ef­fi­ca­cy, first glimpse of el­der­ly da­ta and 100% pro­tec­tion against se­vere dis­ease in US tri­al

5 years ago
R&D

UK drug reg­u­la­tor to restart in­spec­tions at the end of March with a fo­cus on so­cial dis­tanc­ing

5 years ago
FDA+

FDA spells out how the Covid-19 vari­ants im­pact the ef­fec­tive­ness of Re­gen­eron, Eli Lil­ly mAb treat­ments

5 years ago
FDA+

Jakafi failed the pri­ma­ry end­point in a Covid-19 study. But In­cyte is still go­ing to FDA with a com­pas­sion­ate use pitch

5 years ago
R&D

In­side No­var­tis' months-long ef­forts to scale their ri­val­s' Covid-19 vac­cines

5 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Catal­ent, As­traZeneca de­fend vac­cine batch qual­i­ty in safe­ty row — FT; US buys more Covid-19 an­ti­body sup­plies

5 years ago
Manufacturing

EMA calls for As­traZeneca vac­ci­na­tions to con­tin­ue af­ter safe­ty scares de­layed roll­out

5 years ago
FDA+

Covid-19 roundup: Fac­ing sup­ply de­lay, UK fires shot at Eu­rope af­ter EU threat­ens to ban As­traZeneca vac­cine ex­ports

5 years ago

Eli Lil­ly’s Covid-19 drug bam­lanivimab is no longer dis­trib­uted in 3 states be­cause of a vari­ant, Wood­cock says

5 years ago
FDA+

Covid-19 roundup: Al­ny­lam, Vir qui­et­ly de­pri­or­i­tize Covid-19 drug; Da­ta sug­gest As­traZeneca's vac­cine is on­ly 10.4% ef­fec­tive against new vari­ant

5 years ago

Covid-19 roundup: As As­traZeneca deals with vac­cine woes, US turns at­ten­tion to its an­ti­body treat­ment; Mod­er­na dos­es first kids in pe­di­atric vac­cine study 

5 years ago

Covid-19 roundup: Ger­many sus­pends As­traZeneca vac­cine as British drug­mak­er de­fends shot amid blood clot scare

5 years ago

With hopes for an­ti­bod­ies wan­ing, the NIH will test No­var­tis part­ner's nov­el an­tivi­ral in hos­pi­tal­ized Covid-19 pa­tients

5 years ago
R&D

As­traZeneca ex­pects US vac­cine da­ta ‘soon’ — with 50M dos­es ready by the end of April

5 years ago

Covid-19 roundup: As­traZeneca cuts Q1 vac­cine sup­ply to EU by a third — re­port; Sanofi, Trans­late ush­er an­oth­er mR­NA shot in­to clin­ic

5 years ago

No­vavax fi­nal re­sults show 96% ef­fi­ca­cy in UK tri­al but plunge to about 50% in South African vari­ant

5 years ago
First page Previous page 31323334353637 Next page Last page
A service from the Financial Times